cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Fulcrum Therapeutics Inc
9 own
6 watching
Current Price
$7.28
$-0.16
(-2.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
165.68M
52-Week High
52-Week High
13.70000
52-Week Low
52-Week Low
2.43000
Average Volume
Average Volume
0.29M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization165.68M
icon52-Week High13.70000
icon52-Week Low2.43000
iconAverage Volume0.29M
iconDividend Yield--
iconP/E Ratio--
What does the Fulcrum Therapeutics Inc do?
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Fulcrum Therapeutics Inc make?
News & Events about Fulcrum Therapeutics Inc.
Zolmax
9 months ago
Fulcrum Therapeutics (NASDAQ:FULC Free Report) and Lyell Immunopharma (NASDAQ:LYEL Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ...
Globe Newswire
10 months ago
BENSALEM, Pa., June 27, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. ...
Globe Newswire
10 months ago
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fulcrum investors who were adversely...
Globe Newswire
10 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulcrum Therapeutics, Inc. (Fulcrum or the Company) (NASDAQ: FULC), and certain officers. The class action, filed in the United States District Court for the District of New Jersey...
Globe Newswire
10 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Edgio, Inc. (NASDAQ: EGIO), Fulcrum Therapeutics, Inc. (NASDAQ: FULC), adidas AG (OTC: ...
Frequently Asked Questions
Frequently Asked Questions
What is Fulcrum Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Fulcrum Therapeutics Inc shares?
plus_minus_icon
How can I buy Fulcrum Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Fulcrum Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Fulcrum Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Fulcrum Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Fulcrum Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Fulcrum Therapeutics Inc?
plus_minus_icon
What percentage is Fulcrum Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Fulcrum Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.28
$-0.16
(-2.15%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$51.14
$2.30 (4.71 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$4.40
$0.00 (0.00 %)
GENERATION BIO CO
GENERATION BIO CO
$2.99
$-0.27 (-8.28 %)
Annexon Inc
Annexon Inc
$4.45
$0.01 (0.23 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$51.14
$2.30 (4.71 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$4.40
$0.00 (0.00 %)
GENERATION BIO CO
GENERATION BIO CO
$2.99
$-0.27 (-8.28 %)
Annexon Inc
Annexon Inc
$4.45
$0.01 (0.23 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00